Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL

Clinical trial NCT04788472 · COMPLETED

Trial details

NCT number: NCT04788472
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Acute Lymphoblastic Leukemia, Adult

Start date: 2021-03-05
Primary completion: 2024-08-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.